Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hepatitis C, Chronic 3Carcinoma, Hepatocellular 2Recurrence 1Leukemia 1Hepatitis C 1Hematologic Neoplasms 1

Interventions

Ribavirin 4ledipasvir, sofosbuvir drug combination 3sofosbuvir-velpatasvir drug combination 2elbasvir-grazoprevir drug combination 2Sorafenib 2Sofosbuvir 2telaprevir 1rocakinogene sifuplasmid 1pembrolizumab 1peginterferon alfa-2a 1navitoclax 1menatetrenone 1ledipasvir 1hepatitis C immune globulin, human 1grazoprevir 1elbasvir 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Patient Navigation 1Medical Marijuana 1Mass Screening 1Introns 1Immunoglobulin G 1Immunoenzyme Techniques 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hepatitis C × ledipasvir × Clear all
NCT03903185 2023-08-22

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Ain Shams University

Phase 1/2 Completed
24 enrolled
Other hematologic neoplasm

Hepatitis C, Leukemia, Hematologic Neoplasms, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡